Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Mustafa, S Shahzad; Ostrov, David; Yerly, Daniel

Mustafa, S Shahzad; Ostrov, David; Yerly, Daniel.

Afiliación

Mustafa SS; Allergy and Clinical Immunology, Rochester Regional Health System, Rochester, NY, USA. shahzad.mustafa@rochesterregional.org.
Ostrov D; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. shahzad.mustafa@rochesterregional.org.
Yerly D; Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, USA.

Curr Allergy Asthma Rep ; 18(4): 26, 2018 03 24.

Article en En | MEDLINE | ID: mdl-29574562

Asunto(s)

Erupciones por Medicamentos; Erupciones por Medicamentos/diagnóstico; Erupciones por Medicamentos/epidemiología; Erupciones por Medicamentos/terapia; Humanos; Factores de Riesgo

Palabras clave

Acute generalized exanthematous pustulosis (AGEP); Drug reaction with eosinophilia and systemic symptoms (DRESS); HLA-associated drug hypersensitivity; Severe cutaneous adverse drug reaction (SCAR); Stevens-Johnson syndrome (SJS); Toxic epidermal necrolysis (TEN)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Erupciones por Medicamentos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Allergy Asthma Rep Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google